Augmedix/AUGX

$1.16

-4.13%
-
1D1W1MYTD1YMAX

About Augmedix

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Ticker

AUGX

Sector

Industrials

Trading on

NASDAQ

Industry

Computer Services

CEO

Emmanuel Krakaris

Employees

1,430

Headquarters

San francisco, United States

Augmedix Metrics

BasicAdvanced
$59M
Market cap
-
P/E ratio
-$0.43
EPS
-
Beta
-
Dividend rate
$59M
$6.25
$0.99
632K
2.038
72.85
115.035
-19.89%
-44.12%
-280.05%
-79.63%
1.217
3.319
3.333
45.04%
32.56%
39.61%

What the Analysts think about Augmedix

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
200% upside
High $5.90
Low $1.50
$1.16
Current price
$3.48
Average price target

Augmedix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-47.76% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$13M
6.35%
Net income
-$6.4M
45.45%
Profit margin
-47.76%
36.77%

Augmedix Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 94.03%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.12
-$0.10
-$0.09
-$0.26
-
Expected
-$0.13
-$0.12
-$0.10
-$0.13
-$0.14
Surprise
-7.69%
-14.89%
-10%
94.03%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Augmedix stock?

Augmedix (AUGX) has a market cap of $59M as of May 22, 2024.

What is the P/E ratio for Augmedix stock?

The price to earnings (P/E) ratio for Augmedix (AUGX) stock is 0 as of May 22, 2024.

Does Augmedix stock pay dividends?

No, Augmedix (AUGX) stock does not pay dividends to its shareholders as of May 22, 2024.

When is the next Augmedix dividend payment date?

Augmedix (AUGX) stock does not pay dividends to its shareholders.

What is the beta indicator for Augmedix?

Augmedix (AUGX) does not currently have a Beta indicator.

What is the Augmedix stock price target?

The target price for Augmedix (AUGX) stock is $3.48, which is 190% above the current price of $1.2. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Augmedix stock

Buy or sell Augmedix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing